Lifeline Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2009	FY 2004	FY 2003	FY 2002
Period Ending	Dec '09 Dec 31, 2009	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Net Income	-	-1.74	-0.85	-0.86
Depreciation & Amortization	-	0.06	0.05	0.05
Loss (Gain) From Sale of Assets	-	-	-0.22	-
Asset Writedown & Restructuring Costs	-	0.04	0.11	-
Stock-Based Compensation	-	0.25	0.3	-
Other Operating Activities	-	-	0.03	-
Change in Inventory	-	-0.22	-0.11	-
Change in Accounts Payable	-	-0.03	0.07	-0.06
Change in Other Net Operating Assets	-	0	0.49	-
Operating Cash Flow	-	-1.63	-0.13	-0.86
Capital Expenditures	-	-0.04	-0.01	-0.02
Divestitures	-	-	-	0.02
Sale (Purchase) of Intangibles	-	-0.12	-0.05	-
Other Investing Activities	-	-	-0.56	-
Investing Cash Flow	-	-0.16	-0.63	0
Short-Term Debt Issued	-	0.1	0.02	-
Long-Term Debt Issued	-	0.4	0.03	0.04
Total Debt Issued	-	0.5	0.05	0.04
Long-Term Debt Repaid	-	-0	-0.15	-
Net Debt Issued (Repaid)	-	0.5	-0.1	0.04
Issuance of Common Stock	-	0.67	0.98	0.76
Other Financing Activities	-	0.56	0.12	-
Financing Cash Flow	-	1.73	1	0.8
Net Cash Flow	-	-0.06	0.24	-0.05
Free Cash Flow	-	-1.67	-0.14	-0.88
Free Cash Flow Margin	-	-1689.68%	-496.85%	-
Levered Free Cash Flow	-	-0.53	-	-
Unlevered Free Cash Flow	-	-0.53	-	-
Change in Net Working Capital	-	-0.37	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.